Format

Send to

Choose Destination
JAMA. 2016 Feb 16;315(7):691-6. doi: 10.1001/jama.2016.0018.

Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement.

Author information

1
Mount Sinai School of Medicine, New York, New York2James J. Peters Veterans Affairs Medical Center, Bronx, New York.
2
University of California, San Francisco.
3
Group Health Research Institute, Seattle, Washington.
4
University of Wisconsin, Madison.
5
Columbia University, New York, New York.
6
University of Georgia, Athens.
7
Pima County Department of Health, Tucson, Arizona.
8
Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
9
Independent consultant, Washington, DC.
10
Duke University, Durham, North Carolina.
11
Fairfax Family Practice, Fairfax, Virginia13Virginia Commonwealth University, Richmond.
12
New York University, New York.
13
Veterans Affairs Palo Alto Health Care System, Palo Alto, California16Stanford University, Stanford, California.
14
University of Washington, Seattle.
15
Brown University, Providence, Rhode Island.
16
University of North Carolina, Chapel Hill.

Abstract

DESCRIPTION:

New US Preventive Services Task Force (USPSTF) recommendation on screening for autism spectrum disorder (ASD) in young children.

METHODS:

The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of brief, formal screening instruments for ASD administered during routine primary care visits and the benefits and potential harms of early behavioral treatment for young children identified with ASD through screening.

POPULATION:

This recommendation applies to children aged 18 to 30 months who have not been diagnosed with ASD or developmental delay and for whom no concerns of ASD have been raised by parents, other caregivers, or health care professionals.

RECOMMENDATION:

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for ASD in young children for whom no concerns of ASD have been raised by their parents or a clinician. (I statement).

PMID:
26881372
DOI:
10.1001/jama.2016.0018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center